TNFSF14 and COVID-19: In accordance with this finding, we observed a significant increase in soluble TNFSF14 in the BALF of patients with influenza or COVID-19 acute respiratory distress syndrome (ARDS) compared with control patients who underwent routine bronchoscopy for diagnostic purposes and had normal BALF cellularity (Figure 3J).